Cytosorbents Revenue 2012-2025 | CTSO
Cytosorbents revenue from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Cytosorbents Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $36 |
| 2023 | $31 |
| 2022 | $35 |
| 2021 | $43 |
| 2020 | $41 |
| 2019 | $25 |
| 2018 | $23 |
| 2017 | $15 |
| 2016 | $10 |
| 2015 | $5 |
| 2014 | $4 |
| 2013 | $2 |
| 2012 | $1 |
| 2011 | $0 |
|
Cytosorbents Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $9 |
| 2025-06-30 | $10 |
| 2025-03-31 | $9 |
| 2024-12-31 | $9 |
| 2024-09-30 | $9 |
| 2024-06-30 | $9 |
| 2024-03-31 | $9 |
| 2023-12-31 | $3 |
| 2023-09-30 | $9 |
| 2023-06-30 | $9 |
| 2023-03-31 | $9 |
| 2022-12-31 | $9 |
| 2022-09-30 | $8 |
| 2022-06-30 | $8 |
| 2022-03-31 | $9 |
| 2021-12-31 | $11 |
| 2021-09-30 | $10 |
| 2021-06-30 | $12 |
| 2021-03-31 | $11 |
| 2020-12-31 | $12 |
| 2020-09-30 | $11 |
| 2020-06-30 | $10 |
| 2020-03-31 | $9 |
| 2019-12-31 | $7 |
| 2019-09-30 | $6 |
| 2019-06-30 | $6 |
| 2019-03-31 | $5 |
| 2018-12-31 | $6 |
| 2018-09-30 | $6 |
| 2018-06-30 | $6 |
| 2018-03-31 | $5 |
| 2017-12-31 | $5 |
| 2017-09-30 | $4 |
| 2017-06-30 | $4 |
| 2017-03-31 | $3 |
| 2016-12-31 | $3 |
| 2016-09-30 | $2 |
| 2016-06-30 | $2 |
| 2016-03-31 | $2 |
| 2015-12-31 | $2 |
| 2015-09-30 | $1 |
| 2015-06-30 | $1 |
| 2015-03-31 | $1 |
| 2014-12-31 | $1 |
| 2014-09-30 | $1 |
| 2014-06-30 | $1 |
| 2014-03-31 | $1 |
| 2013-12-31 | $1 |
| 2013-09-30 | $1 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $1 |
| 2012-09-30 | $1 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $0 |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.042B | $0.036B |
| CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $188.859B | 21.09 |
| EssilorLuxottica (ESLOY) | France | $145.490B | 0.00 |
| Stryker (SYK) | United States | $137.164B | 27.23 |
| Boston Scientific (BSX) | United States | $135.332B | 30.95 |
| Medtronic (MDT) | Ireland | $129.919B | 18.00 |
| Medline (MDLN) | United States | $60.378B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.195B | 0.00 |
| Agilent Technologies (A) | United States | $39.301B | 24.84 |
| GE HealthCare Technologies (GEHC) | United States | $37.303B | 17.84 |
| ResMed (RMD) | United States | $37.266B | 25.79 |
| Koninklijke Philips (PHG) | Netherlands | $28.637B | 18.70 |
| Terumo (TRUMY) | Japan | $20.358B | 22.92 |
| Insulet (PODD) | United States | $19.697B | 61.13 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.349B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.055B | 0.00 |
| Baxter (BAX) | United States | $10.317B | 8.33 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.233B | 29.60 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.455B | 13.57 |
| BillionToOne (BLLN) | United States | $4.145B | 0.00 |
| Envista Holdings (NVST) | United States | $4.014B | 23.03 |
| ICU Medical (ICUI) | United States | $3.914B | 24.85 |
| Haemonetics (HAE) | United States | $3.278B | 14.59 |
| Prestige Consumer Healthcare (PBH) | United States | $3.257B | 14.85 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Neogen (NEOG) | United States | $2.159B | 47.26 |
| QuidelOrtho (QDEL) | United States | $2.076B | 13.35 |
| Perrigo (PRGO) | Ireland | $2.075B | 5.20 |
| AtriCure (ATRC) | United States | $1.990B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.945B | 39.15 |
| Curaleaf Holdings (CURLF) | Canada | $1.764B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.687B | 16.85 |
| Green Thumb Industries (GTBIF) | United States | $1.649B | 72.27 |
| Kestra Medical Technologies (KMTS) | United States | $1.442B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.422B | 20.59 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.390B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.251B | 371.14 |
| Capricor Therapeutics (CAPR) | United States | $1.105B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.064B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.979B | 0.00 |
| InMode (INMD) | Israel | $0.890B | 10.06 |
| Valneva SE (VALN) | France | $0.886B | 0.00 |
| Omeros (OMER) | United States | $0.861B | 0.00 |
| CeriBell (CBLL) | United States | $0.842B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.602B | 16.32 |
| Verano Holdings (VRNO) | United States | $0.516B | 0.00 |
| Cerus (CERS) | United States | $0.503B | 0.00 |
| Brainsway (BWAY) | Israel | $0.474B | 80.63 |
| Canopy Growth (CGC) | Canada | $0.431B | 0.00 |
| SNDL (SNDL) | Canada | $0.428B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.426B | 0.00 |
| Quanterix (QTRX) | United States | $0.337B | 0.00 |
| Evolus (EOLS) | United States | $0.329B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.282B | 22.51 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.245B | 144.33 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.235B | 0.00 |
| High Tide (HITI) | Canada | $0.230B | 0.00 |
| Organigram Global (OGI) | Canada | $0.219B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Utah Medical Products (UTMD) | United States | $0.199B | 17.54 |
| Sanara MedTech (SMTI) | United States | $0.198B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.195B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.183B | 0.00 |
| Accendra Health (ACH) | United States | $0.163B | 1.64 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 0.00 |
| Apyx Medical (APYX) | United States | $0.151B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.132B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.77 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Exagen (XGN) | United States | $0.111B | 0.00 |
| Biote (BTMD) | United States | $0.104B | 4.56 |
| Sharps Technology (STSS) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 25.23 |
| Nephros (NEPH) | United States | $0.050B | 35.85 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Veru (VERU) | United States | $0.043B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Bonk (BNKK) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.27 |
| Jin Medical (ZJYL) | China | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |